share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Officer Mock James M

SEC announcement ·  Apr 10 04:13
Summary by Futu AI
Moderna's Chief Financial Officer, James M. Mock, completed a sale of 705 shares of the company's common stock on April 8, 2024. The transaction was executed at a price of $101.9281 per share, resulting in a total market value of $71,859.31. Prior to this sale, Mock had acquired 1,453 shares through the exercise of derivative securities on April 5, 2024. Following these transactions, Mock's direct holdings in Moderna amount to 5,048 shares. The sale represents an open market transaction, indicating a potential cash-in on the part of the CFO, while the acquisition reflects the exercise of options or similar securities.
Moderna's Chief Financial Officer, James M. Mock, completed a sale of 705 shares of the company's common stock on April 8, 2024. The transaction was executed at a price of $101.9281 per share, resulting in a total market value of $71,859.31. Prior to this sale, Mock had acquired 1,453 shares through the exercise of derivative securities on April 5, 2024. Following these transactions, Mock's direct holdings in Moderna amount to 5,048 shares. The sale represents an open market transaction, indicating a potential cash-in on the part of the CFO, while the acquisition reflects the exercise of options or similar securities.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.